- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.08. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| FIREFLY NEUROSCIENCE Aktie jetzt für 0€ handeln | |||||
| 05.08. | Firefly Neuroscience, Inc.: Firefly Neuroscience (NASDAQ: AIFF) Reports 291% Increase in TMS Center Customer Brain Scan Volumes | 402 | GlobeNewswire (Europe) | KENMORE, N.Y., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly" or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company advancing precision neuroscience... ► Artikel lesen | |
| 28.07. | Firefly Neuroscience, Inc.: Firefly Neuroscience (NASDAQ: AIFF) and Next Health Launch Precision Cognitive Health Initiative as FDA Advisory Committee's Recommendation Backs Broader Access to Key Neuroprotective Peptides | 1 | GlobeNewswire (USA) | ||
| 22.06. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 02.06. | Firefly Neuroscience identifies PTSD biomarker using AI | 2 | Investing.com | ||
| 02.06. | Firefly Neuroscience, Inc.: Firefly's AI-Driven Evoke System Powers Discovery of Novel Electrophysiological Biomarker for PTSD | 1 | GlobeNewswire (USA) | ||
| 20.05. | FIREFLY NEUROSCIENCE, INC. - S-8, Securities to be offered to employees in employee benefit plans | 3 | SEC Filings | ||
| 13.05. | FIREFLY NEUROSCIENCE, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 12.05. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.04. | Firefly Neuroscience sichert sich 8 Millionen US-Dollar durch weitere Privatplatzierung | - | Investing.com Deutsch | ||
| 22.04. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | - | SEC Filings | ||
| 13.04. | Firefly Neuroscience, Inc.: With Brain Scan Volume Momentum Accelerating, Firefly Makes History by Building the World's First Known 200,000+ Standardized EEG/ERP Depository | 7 | GlobeNewswire (USA) | ||
| 31.03. | FIREFLY NEUROSCIENCE, INC. - 10-K, Annual Report | 2 | SEC Filings | ||
| 26.03. | Firefly Neuroscience Shares Jump 39% On US Military Brain Health Partnership | 3 | RTTNews | ||
| 26.03. | Firefly Neuroscience, Inc.: Firefly Confirms Public-Private Partnership with the Department of War | 780 | GlobeNewswire (Europe) | Firefly's AI-powered, FDA-cleared EEG/ERP Technology is Being Deployed to Support Assessment and Treatment of PTSD and TBI in U.S. Service Members Partnership Represents a Significant Expansion of... ► Artikel lesen | |
| 13.03. | Forschung zu ADHS-Subtypen beflügelt Aktie von Firefly Neuroscience | 15 | Investing.com Deutsch | ||
| 13.03. | Firefly Neuroscience, Inc.: Firefly Announces Discovery of New Brain Wave Biomarkers For Differential Diagnosis of ADHD | 521 | GlobeNewswire (Europe) | Over 22 million Americans are diagnosed with ADHD - yet an objective biological marker for distinguishing between its three distinct subtypes has, to date, remained elusive1 Firefly's AI-powered EEG/ERP... ► Artikel lesen | |
| 12.03. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 06.03. | What's Going On With Firefly Neuroscience Stock On Friday? | 2 | Benzinga.com | ||
| 04.03. | Firefly Neuroscience Skyrockets - Brain Scan Breakthrough Fuels Rally | 33 | Benzinga.com |
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 46,355 | +1,11 % | EQS-News: Fresenius SE & Co. KGaA: Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen Euro | EQS-News: Fresenius SE & Co. KGaA
/ Schlagwort(e): Beteiligung/Unternehmensbeteiligung
Fresenius verkauft 7,8 Millionen Fresenius Medical Care-Aktien im Wert von rund 300 Millionen... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 39,540 | -0,40 % | Siemens-Healthineers-Chef: 'Mir gefällt dieses Rumgenörgel nicht' | BERLIN (dpa-AFX) - Der Vorstandvorsitzende des Dax -Konzerns Siemens Healthineers, Bernhard Montag, hat die Anspruchshaltung vieler Wirtschaftslenker in Deutschland gegenüber der Politik kritisiert.... ► Artikel lesen | |
| ECKERT & ZIEGLER | 13,180 | 0,00 % | BERENBERG stuft ECKERT & ZIEGLER auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat die Einstufung für Eckert & Ziegler mit einem Kursziel von 23 Euro auf "Buy" belassen. Die operative Grundleistung des Herstellers radioaktiver... ► Artikel lesen | |
| UNITEDHEALTH | 344,60 | +1,47 % | Billionaire David Tepper Sold Every Single Share of UnitedHealth in Q2. Here's Whether He Made a Costly Mistake. | ||
| TELADOC HEALTH | 5,392 | +1,62 % | BetterHelp Has the Demand: Can Teladoc Build the Capacity? | ||
| M1 AESTHETICS | 12,700 | -0,78 % | Dividendenbekanntmachungen (08.07.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) A2 MILK COMPANY LIMITED NZATME0002S8 0,4135 NZD 0,2059 EUR AGRANA BETEILIGUNGS-AG AT000AGRANA3 - 0,35 EUR BANK OF CHONGQING CO LTD CNE100001QN2 0... ► Artikel lesen | |
| BECTON DICKINSON | 161,55 | -0,62 % | What's Going On With Becton Dickinson Stock Wednesday? | ||
| BOSTON SCIENTIFIC | 40,780 | -4,50 % | Stifel maintains Boston Scientific stock rating after cyber incident | ||
| INMODE | 12,875 | +0,04 % | InMode Ltd.: InMode Reports Second Quarter 2026 Financial Results: Quarterly GAAP Revenues of $95.6 Million, Consistent with the Second Quarter of 2025 | YOKNEAM, Israel, Aug. 5, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,230 | 0,00 % | Co-Diagnostics Reports Second Quarter 2026 Financial Results | Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion
Strengthening Integrated Co-Dx PCR Platform Through Scientific... ► Artikel lesen | |
| CYTOSORBENTS | 0,274 | 0,00 % | Cytosorbents Corp: CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update | Highlighting Four Independent Drivers of Shareholder Value
PRINCETON, N.J., Aug. 6, 2026 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the... ► Artikel lesen | |
| CLOVER HEALTH INVESTMENTS | 3,580 | +1,13 % | CLOVER HEALTH INVESTMENTS, CORP. /DE - 8-K, Current Report | ||
| NANO-X IMAGING | 0,855 | -0,93 % | Nano-X Imaging Ltd: Nanox to Report Second Quarter 2026 Financial Results on September 9, 2026 | ||
| FULGENT GENETICS | 17,000 | -0,58 % | Fulgent expects $330M-$340M 2026 revenue as billing transition lowers collection rates | ||
| ARJO | 2,568 | -0,08 % | Arjo AB: Arjo's interim report January-June 2026 | "We grew by 4.7% organically in the quarter, driven by high demand for our products and solutions. We are also now taking important steps to enhance our focus, efficiency, and profitability - and to... ► Artikel lesen |
Das Unternehmen FIREFLY NEUROSCIENCE INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell +1,94 % bei einem Aktienkurs von 1,050 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu FIREFLY NEUROSCIENCE INC finden Sie auf Wallstreet Online.